Status and phase
Conditions
Treatments
About
This study is being conducted to measure the amount of study drug that is in your blood after you receive a different type of tablet in each of four study visits.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Healthy adult males and females between 18 and 60 years of age, inclusive. Whether a subject is "healthy" will be determined by a responsible physician, based on a medical evaluation including history, physical examination, laboratory tests, cardiac monitoring.
To be eligible, female subjects must have a negative pregnancy test (i.e. serum hCG test) and be of:
Male subjects must agree to abstain from or use a condom during sexual intercourse with pregnant or lactating females; or use a condom/spermicide, in addition to having their female partner use another form of contraception, such as an IUD, diaphragm with spermicide, oral contraceptive, inject able progesterone, or sub dermal implant if engaging in sexual intercourse with a female partner who could become pregnant. This criterion must be followed from the time of the first dose of study medication until completion of follow up procedures.
Body weight >/ 50 kg (110 pounds) for men and >/ 45 kg (99 pounds) for women and body mass index (BMI) between 19 and 31.
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin within reference range at screening.
Signed and dated written informed consent prior to admission to the study. The subject is able to understand and comply with protocol requirements, instructions and protocol-stated restrictions
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal